moxifloxacin has been researched along with l 743,872 in 3 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (l 743,872) | Trials (l 743,872) | Recent Studies (post-2010) (l 743,872) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 1,724 | 75 | 849 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Balcıoğlu, IC; Eraç, B; Gürpınar, T; Hoşgör-Limoncu, M; Limoncu, ME; Özbilgin, A | 1 |
| El-Najjar, N; Gessner, A; Hösl, J | 1 |
| Poilvache, H; Ruiz-Sorribas, A; Van Bambeke, F | 1 |
3 other study(ies) available for moxifloxacin and l 743,872
| Article | Year |
|---|---|
Investigation of in vitro antileishmanial activity of moxifloxacin, linezolid and caspofungin on Leishmania tropica promastigotes.
Topics: Acetamides; Aza Compounds; Caspofungin; Echinocandins; Fluoroquinolones; Leishmania tropica; Linezolid; Lipopeptides; Moxifloxacin; Oxazolidinones; Quinolines; Trypanocidal Agents | 2013 |
Liquid chromatography-tandem mass spectrometry for the quantification of moxifloxacin, ciprofloxacin, daptomycin, caspofungin, and isavuconazole in human plasma.
Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Chromatography, High Pressure Liquid; Ciprofloxacin; Daptomycin; Echinocandins; Fluoroquinolones; Humans; Limit of Detection; Lipopeptides; Moxifloxacin; Nitriles; Plasma; Pyridines; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazoles | 2018 |
Pharmacodynamics of Moxifloxacin, Meropenem, Caspofungin, and Their Combinations against
Topics: Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Escherichia coli; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Staphylococcus aureus | 2022 |